ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 15, Pages 3373
Publisher
MDPI AG
Online
2021-07-29
DOI
10.3390/jcm10153373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
- (2021) Matteo Calligaris et al. MOLECULES
- ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment
- (2021) Nathalie Théret et al. Cancers
- Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo
- (2020) Hong-Yuan Lu et al. LIFE SCIENCES
- GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17
- (2020) Subbroto Kumar Saha et al. Molecular Therapy-Oncolytics
- Role of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Dysfunction
- (2020) Mi Zhou et al. Frontiers in Cell and Developmental Biology
- TGF-β Induced CTGF Expression in Human Lung Epithelial Cells through ERK, ADAM17, RSK1, and C/EBPβ Pathways
- (2020) Shu-Ching Ou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The molecular, cellular and pathophysiological roles of iRhom pseudoproteases
- (2019) Iqbal Dulloo et al. Open Biology
- The metalloprotease ADAM17 in inflammation and cancer
- (2019) Stefan Düsterhöft et al. PATHOLOGY RESEARCH AND PRACTICE
- Functions of ‘A disintegrin and metalloproteases (ADAMs)’ in the mammalian nervous system
- (2019) Hung-En Hsia et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
- (2019) Bin Yang et al. Cell Death & Disease
- A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer
- (2019) Rohan Kar et al. Genes
- Regulation of Fibrotic Processes in the Liver by ADAM Proteases
- (2019) Dirk Schmidt-Arras et al. Cells
- Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments
- (2018) Stefan F Lichtenthaler et al. EMBO JOURNAL
- ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma
- (2018) Yong Li et al. EXPERIMENTAL CELL RESEARCH
- Regulation of profibrotic responses by ADAM17 activation in high glucose requires its C-terminus and FAK
- (2018) Renzhong Li et al. JOURNAL OF CELL SCIENCE
- ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
- (2018) Stefanie Schmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
- (2018) Yingshi Zhang et al. Cell Death & Disease
- Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
- (2017) Marcia L. Moss et al. MEDIATORS OF INFLAMMATION
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
- (2017) Joseph Dosch et al. Oncotarget
- Role of epithelial–mesenchymal transition in proliferative vitreoretinopathy
- (2016) Shigeo Tamiya et al. EXPERIMENTAL EYE RESEARCH
- ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells
- (2016) Min Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Role of epithelial to mesenchymal transition in hepatocellular carcinoma
- (2016) Gianluigi Giannelli et al. JOURNAL OF HEPATOLOGY
- ADAMs family and relatives in cardiovascular physiology and pathology
- (2016) Pu Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways
- (2016) Jinbing Sun et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method
- (2016) Ganglong Yang et al. MOLECULES
- The role of ADAM17 in tumorigenesis and progression of breast cancer
- (2016) Hongyu Shen et al. TUMOR BIOLOGY
- Phosphatidylserine exposure is required for ADAM17 sheddase function
- (2016) Anselm Sommer et al. Nature Communications
- Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation
- (2016) SungWoo Hong et al. Oncotarget
- Control of ADAM17 activity by regulation of its cellular localisation
- (2016) Inken Lorenzen et al. Scientific Reports
- iRhoms in the brain – a new frontier?
- (2015) Stefan F Lichtenthaler et al. CELL CYCLE
- The Effect of cAMP-PKA Activation on TGF-β1-Induced Profibrotic Signaling
- (2015) Lin Weng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Loss of ADAM17 is associated with severe multiorgan dysfunction
- (2015) Robert H.J. Bandsma et al. HUMAN PATHOLOGY
- Integrin-linked kinase mediates CTGF-induced epithelial to mesenchymal transition in alveolar type II epithelial cells
- (2015) Mitra Shafieian et al. PEDIATRIC RESEARCH
- Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
- (2015) Michael Kreuter et al. Biomed Research International
- MicroRNAs as potential targets for progressive pulmonary fibrosis
- (2015) Subbiah Rajasekaran et al. Frontiers in Pharmacology
- ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-κB-dependent activation of Snail
- (2015) Magdalena A. Cichon et al. Oncotarget
- ADAM17 at the interface between inflammation and autoimmunity
- (2014) Sabrina Lisi et al. IMMUNOLOGY LETTERS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cell Stress Induces Upregulation of Osteopontin via the ERK Pathway in Type II Alveolar Epithelial Cells
- (2014) Aki Kato et al. PLoS One
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial–mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance
- (2014) Young-Joo Kim et al. TOXICOLOGY
- Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1–7
- (2013) Bruce D. Uhal et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
- (2013) Norihiko Sakai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-α cleavage by ADAM17
- (2013) Ming-Qing Gao et al. CANCER LETTERS
- TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion
- (2013) Orsi Giricz et al. INTERNATIONAL JOURNAL OF CANCER
- Thrombin-Induced CCAAT/Enhancer-Binding Protein Activation and IL-8/CXCL8 Expression via MEKK1, ERK, and p90 Ribosomal S6 Kinase 1 in Lung Epithelial Cells
- (2013) C.-H. Lin et al. JOURNAL OF IMMUNOLOGY
- iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding
- (2013) T. Maretzky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antifibrotic Activity of Sorafenib in Experimental Hepatic Fibrosis: Refinement of Inhibitory Targets, Dosing, and Window of Efficacy In Vivo
- (2012) Feng Hong et al. DIGESTIVE DISEASES AND SCIENCES
- Sjögren’s syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB
- (2012) M Sisto et al. GENES AND IMMUNITY
- New lives for old: evolution of pseudoenzyme function illustrated by iRhoms
- (2012) Colin Adrain et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ADAM17 Silencing in Mouse Colon Carcinoma Cells: The Effect on Tumoricidal Cytokines and Angiogenesis
- (2012) Sudipta Das et al. PLoS One
- Differential expression of the ADAMs in developing chicken retina
- (2011) Xin Yan et al. DEVELOPMENT GROWTH & DIFFERENTIATION
- The role of ADAM-mediated shedding in vascular biology
- (2011) Daniela Dreymueller et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes
- (2011) Yue-Lei Chen et al. HEPATOLOGY
- Epithelial–mesenchymal transition in chronic liver disease: Fibrogenesis or escape from death?
- (2011) Massimo Pinzani JOURNAL OF HEPATOLOGY
- Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB
- (2011) Sabrina Lisi et al. LABORATORY INVESTIGATION
- ADAM-17 Is Activated by the Mitogenic Protein Kinase ERK in a Model of Kidney Fibrosis
- (2010) L. Gabriel Navar et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- ADAM-17: A Target to Increase Chemotherapeutic Efficacy in Colorectal Cancer?
- (2010) A. M. Lee et al. CLINICAL CANCER RESEARCH
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin–TACE–amphiregulin axis
- (2010) Sabrina Lisi et al. JOURNAL OF AUTOIMMUNITY
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
- (2010) Yan Wang et al. JOURNAL OF HEPATOLOGY
- ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin
- (2010) J Malapeira et al. ONCOGENE
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
- (2009) Thomas Amann et al. CANCER SCIENCE
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- ADAM10-Mediated E-Cadherin Release Is Regulated by Proinflammatory Cytokines and Modulates Keratinocyte Cohesion in Eczematous Dermatitis
- (2008) Thorsten Maretzky et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The ADAM metalloproteinases
- (2008) D EDWARDS et al. MOLECULAR ASPECTS OF MEDICINE
- Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
- (2008) F. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
- The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer
- (2008) Jessica Pruessmeyer et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: Physiological and cellular functions
- (2008) Karina Reiss et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now